文献速递新发突发、热带与寄生虫病

肯尼亚Kilifi地区不同严重程度儿童疟疾感染的血浆PfHRP2浓度研究

Plasma Plasmodium falciparum Histidine-rich Protein 2 Concentrations in Children With Malaria Infections of Differing Severity in Kilifi, Kenya.
PubMed 文献 · Clin Infect Dis · 2021-01-01

本研究在肯尼亚Kilifi地区比较了三组疟疾感染儿童的血浆PfHRP2浓度与寄生虫负荷:WHO定义的重症疟疾组(n=1544)、入院但无重症特征的疟疾组(n=200)及社区无症状寄生虫血症组(n=33)。结果显示外周寄生虫血症以无并发症疟疾最高,而血浆PfHRP2浓度随病情严重程度升高;合并血流或脑脊液侵袭性细菌感染的重症疟疾患儿PfHRP2浓度显著低于无此类合并感染者。结论认为疟疾临床严重程度与寄生虫总负荷密切相关,定量检测血浆PfHRP2可能有助于识别临床风险最高的儿童及疟疾非主要病因的危重患儿。

要点

  • 外周寄生虫血症以无并发症疟疾最高,约为重症疟疾的近3倍、无症状者的100倍以上。
  • 血浆PfHRP2浓度随疟疾严重程度升高,重症疟疾组最高。
  • 合并侵袭性细菌感染的重症疟疾患儿PfHRP2浓度显著低于无合并感染者。

核心结论

  • 疟疾感染的临床严重程度与恶性疟原虫寄生虫总负荷密切相关。
  • 定量检测血浆PfHRP2浓度可能有助于识别临床风险最高的儿童以及疟疾非主要病因的危重儿童。

研究设计与样本

  • 研究纳入三组儿童:WHO定义的重症疟疾患儿n=1544、入院但无重症特征的疟疾患儿n=200、社区无症状寄生虫血症儿童n=33。
  • 研究估算并比较各组恶性疟原虫寄生虫负荷及血浆PfHRP2浓度。

主要发现

  • 外周寄生虫血症几何均数在无并发症疟疾组为111 064/μL(95%CI 86 798-141 819/μL),约为重症疟疾组39 588/μL(95%CI 34 990-44 791/μL)的3倍,超过无症状组1092/μL(95%CI 523-2280/μL)的100倍。
  • 血浆PfHRP2几何均值随严重程度升高:无症状疟疾7 ng/mL(95%CI 4-12 ng/mL),无并发症疟疾843 ng/mL(95%CI 655-1084 ng/mL),重症疟疾1369 ng/mL(95%CI 1244-1506 ng/mL)。
  • 合并血流或脑脊液侵袭性细菌感染的重症疟疾患儿PfHRP2几何均值312 ng/mL(95%CI 175-557 ng/mL),显著低于无此类感染者1439 ng/mL(95%CI 1307-1584 ng/mL),P < .001。

临床怎么用

  • 对儿童疟疾患者可考虑定量检测血浆PfHRP2浓度以辅助评估临床风险。
  • 重症疟疾患儿PfHRP2浓度明显偏低时需警惕合并侵袭性细菌感染、疟疾可能非主要病因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most previous studies support a direct link between total parasite load and the clinical severity of Plasmodium falciparum malaria infections. METHODS: We estimated P. falciparum parasite loads in 3 groups of children with malaria infections of differing severity: (1) children with World Health Organization-defined severe malaria (n = 1544), (2) children admitted with malaria but without features of severity (n = 200), and (3) children in the community with asymptomatic parasitemia (n = 33). RESULTS: Peripheral parasitemias were highest in those with uncomplicated malaria (geometric mean [GM] parasite count, 111 064/μL; 95% confidence interval, CI, 86 798-141 819/μL), almost 3 times higher than in those with severe malaria (39 588/μL; 34 990-44 791/μL) and >100 times higher than in those with asymptomatic malaria (1092/μL; 523-2280/μL). However, the GM P. falciparum histidine-rich protein 2 (PfHRP2) values (95% CI) increased with severity, being 7 (4-12) ng/mL in asymptomatic malaria, 843 (655-1084) ng/mL in uncomplicated malaria, and 1369 (1244-1506) ng/mL in severe malaria. PfHRP2 concentrations were markedly lower in the subgroup of patients with severe malaria and concomitant invasive bacterial infections of blood or cerebrospinal fluid (GM concentration, 312 ng/mL; 95% CI, 175-557 ng/mL; P < .001) than in those without such infections (1439 ng/mL; 1307-1584; P < .001). CONCLUSIONS: The clinical severity of malaria infections related strongly to the total burden of P. falciparum parasites. A quantitative test for plasma concentrations of PfHRP2 could be useful in identifying children at the greatest clinical risk and identifying critically ill children in whom malaria is not the primary cause.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Uyoga S, Wanjiku P, Rop JC, et al. Plasma Plasmodium falciparum Histidine-rich Protein 2 Concentrations in Children With Malaria Infections of Differing Severity in Kilifi, Kenya. Clin Infect Dis. 2021. PMID: 32772115. doi:10.1093/cid/ciaa1141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。